These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 34973823)

  • 1. Health crisis: What opportunities for clinical drug research?
    Deplanque D; Cviklinski S; Bardou M; Ader F; Blanchard H; Barthélémy P; David I; D'Ortenzio E; Espérou H; Launay O; Lazarevic M; Lechat P; Lethiec F; Levy Y; Pérol D; Rage V; Roustit M; Thabut G
    Therapie; 2022; 77(1):59-67. PubMed ID: 34973823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown].
    Ghrieb Z; Allaoua S; Huang J; Langner N; François F; Maréchal C; Jebali M; Lebbé C; Chellah A; Bergeron A; Kiladjian JJ; Daltro De Oliveira R; Soret-Dulphy J; Benajiba L
    Therapie; 2021; 76(4):347-358. PubMed ID: 33640116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organisation of cross-sector collaboration and its influence on crisis management effectiveness among pharmaceutical supply chain stakeholders during the COVID-19 pandemic.
    Latonen SH; Suominen RM; Juppo AM; Airaksinen M; Seeck H
    Public Health; 2023 Sep; 222():196-204. PubMed ID: 37567019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From chaos to a new norm: The Birmingham experience of restructuring the largest plastics department in the UK in response to the COVID-19 pandemic.
    Leng C; Challoner T; Hausien O; Filobbos G; Baden J
    J Plast Reconstr Aesthet Surg; 2020 Dec; 73(12):2136-2141. PubMed ID: 33039307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK.
    Jandu R; Naraynassamy C; Sreeharan N
    Pharmaceut Med; 2022 Oct; 36(5):275-278. PubMed ID: 35902537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
    Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
    Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Approaches to Regulatory Innovation Emerging During the Crucible of COVID-19 : In Responding to a Global Health Crisis, Industry is Discovering New, Efficient Ways of Meeting Objectives.
    Wegner M
    Ther Innov Regul Sci; 2021 Mar; 55(2):463-466. PubMed ID: 33237474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pandemic and resilience for the future: AccBio 2021.
    McGovern ĀT; Salisbury CM; Nyberg GB
    Biotechnol Prog; 2022 Jan; 38(1):e3207. PubMed ID: 34463436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from the pandemic on the value of research infrastructure.
    Roope LSJ; Candio P; Kiparoglou V; McShane H; Duch R; Clarke PM
    Health Res Policy Syst; 2021 Apr; 19(1):54. PubMed ID: 33794906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons?
    Hanney SR; Wooding S; Sussex J; Grant J
    Health Res Policy Syst; 2020 Jun; 18(1):61. PubMed ID: 32513202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
    Crow RA; Hart KA; McDermott MP; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Hirtz D; Lochmuller H; Straub V; Ciafaloni E; Shieh PB; Spinty S; Childs AM; Manzur AY; Morandi L; Butterfield RJ; Horrocks I; Roper H; Flanigan KM; Kuntz NL; Mah JK; Morrison L; Darras BT; von der Hagen M; Schara U; Wilichowski E; Mongini T; McDonald CM; Vita G; Barohn RJ; Finkel RS; Wicklund M; McMillan HJ; Hughes I; Pegoraro E; Bryan Burnette W; Howard JF; Thangarajh M; Campbell C; Griggs RC; Bushby K; Guglieri M
    Trials; 2018 May; 19(1):291. PubMed ID: 29793540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned from the COVID-19 pandemic about sample access for research in the UK.
    Sims JM; Lawrence E; Glazer K; Gander A; Fuller B; Davidson BR; Garibaldi J; Quinlan PR
    BMJ Open; 2022 Apr; 12(4):e047309. PubMed ID: 35428611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
    Cagnazzo C; Besse MG; Manfellotto D; Minghetti P; Cazzaniga S; Cottini L; Fontanella A; Maruti I; Stabile S; Testoni S; Trogu P; Sinno V; Gussoni G
    Tumori; 2021 Feb; 107(1):6-11. PubMed ID: 33297885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical care in hospitalized patients. (Management of the COVID-19 pandemic crisis. A new challenge for pharmacy services).
    Sevilla-Sánchez D; Tuset-Creus M
    Farm Hosp; 2020 Jun; 44(7):28-31. PubMed ID: 32533666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter on "Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK - experience from the ActWELL trial".
    Bruhn H; Anderson AS; Hickman A; Macaskill EJ; Treweek S
    Trials; 2021 Jun; 22(1):381. PubMed ID: 34090495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of drug development during the COVID-19 pandemic: Key considerations for clinical trial designs.
    Shi J; Xiao Y; Zhang Y; Geng D; Cong D; Shi KX; Knapp RJ
    Br J Clin Pharmacol; 2021 May; 87(5):2170-2185. PubMed ID: 33119136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Crisis management, highlighting new opportunities for organisation management in psychiatry].
    Vigné C
    Soins Psychiatr; 2020; 41(331):21-24. PubMed ID: 33357663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?].
    El-Hage W; Hingray C; Lemogne C; Yrondi A; Brunault P; Bienvenu T; Etain B; Paquet C; Gohier B; Bennabi D; Birmes P; Sauvaget A; Fakra E; Prieto N; Bulteau S; Vidailhet P; Camus V; Leboyer M; Krebs MO; Aouizerate B
    Encephale; 2020 Jun; 46(3S):S73-S80. PubMed ID: 32370984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and Data Sharing of COVID-19 Pandemic Information.
    Gao F; Tao L; Huang Y; Shu Z
    Biopreserv Biobank; 2020 Dec; 18(6):570-580. PubMed ID: 33320734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.